Answers are grounded in this paper and cite their sources.
Background: Proliferative diabetic retinopathy (PDR) requires treatment to preserve visual function, but the comparative outcomes of panretinal photocoagulation (PRP) and different early vitrectomy strategies remain incompletely characterised. Objective: To compare functional and anatomical outcomes and postoperative complications following PRP and four vitrectomy-based approaches. Methods: In this prospective, randomised study, 121 patients with PDR were allocated to vitrectomy without PRP (n = 22), vitrectomy with deferred PRP (n = 24), vitrectomy with intraoperative PRP (n = 26), preoperative anti-vascular endothelial growth factor injection followed by vitrectomy without PRP (n = 22), or three sessions of PRP alone (n = 27). Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were assessed at baseline and at 1, 3 and 6 months. Postoperative complications were recorded. Results: At 6 months, BCVA improved significantly only in the PRP-only group, from 0.45 ± 0.25 to 0.60 ± 0.24 (P < 0.05). CRT decreased significantly following vitrectomy with intraoperative PRP (287 ± 31.25 to 229 ± 11.11 μm) and with deferred PRP (242 ± 17.2 to 211 ± 12.1 μm), both P < 0.05. Vitreous haemorrhage occurred in 11.1% of patients receiving PRP alone, while ocular hypertension occurred in 13.6% following vitrectomy without PRP. Conclusion: PRP demonstrated the greatest improvement in BCVA at 6 months. Significant anatomical improvement, characterised by CRT reduction, was observed following vitrectomy with intraoperative PRP. Vitrectomy without PRP was associated with a higher incidence of postoperative complications. These findings suggest complementary roles for laser therapy and vitrectomy in PDR management.
No takes yet. Share an insight, caveat, or question.
Ponomarev et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: